Who owns Cellectar Biosciences, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CLRB from SEC Form 13F filings across 29 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 29 institutions disclosed 3.3M shares of Cellectar Biosciences, Inc. worth $9.1M — about 26.6% of shares outstanding; the largest disclosed holder is Caligan Partners LP. Source: SEC Form 13F filings, parsed by EvidInvest.
29
13F holders
$9.1M
value, 2026 filers
26.6%
of shares outstanding (3.3M sh)
14
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CLRB's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Caligan Partners LPNEW | 469,998 | $1.3M | 0.1% | 3.8% | new |
| 2 | STEMPOINT CAPITAL LPNEW | 354,938 | $986,728 | 0.2% | 2.9% | new |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 327,367 | $910,080 | 0.0% | 2.7% | +299.8% |
| 4 | SILVERARC CAPITAL MANAGEMENT, LLCNEW | 321,728 | $894,404 | 0.1% | 2.6% | new |
| 5 | Bleichroeder LP | 288,679 | $802,528 | 0.1% | 2.4% | +188.7% |
| 6 | Jupiter Topco LLCNEW | 274,156 | $759,412 | 0.0% | 2.2% | new |
| 7 | Balyasny Asset Management L.P.NEW | 220,000 | $611,600 | 0.0% | 1.8% | new |
| 8 | Nantahala Capital Management, LLCNEW | 219,998 | $611,594 | 0.0% | 1.8% | new |
| 9 | Empery Asset Management, LPNEW | 189,605 | $527,102 | 0.6% | 1.6% | new |
| 10 | DIADEMA PARTNERS LPNEW | 138,341 | $384,588 | 0.0% | 1.1% | new |
| 11 | Stonepine Capital Management, LLCNEW | 104,550 | $290,649 | 0.2% | 0.9% | new |
| 12 | Persistent Asset Partners LtdNEW | 92,983 | $258,493 | 0.1% | 0.8% | new |
| 13 | BOOTHBAY FUND MANAGEMENT, LLCNEW | 85,069 | $236,492 | 0.0% | 0.7% | new |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 53,351 | $148,323 | 0.0% | 0.4% | +1.1% |
| 15 | VANGUARD FIDUCIARY TRUST CO | 46,220 | $128,492 | 0.0% | 0.4% | +178.9% |
| 16 | Sequoia Financial Advisors, LLC | 21,850 | $60,743 | 0.0% | 0.2% | +15.9% |
| 17 | ACADIAN ASSET MANAGEMENT LLCNEW | 16,577 | $46,000 | 0.0% | 0.1% | new |
| 18 | NORTHERN TRUST CORPNEW | 14,839 | $41,252 | 0.0% | 0.1% | new |
| 19 | Riverview Capital Advisers, LLC | 10,384 | $50,051 | 0.0% | 0.1% | 0.0% |
| 20 | BlackRock, Inc. | 4,735 | $13,163 | 0.0% | 0% | -0.2% |
| 21 | UBS Group AG | 3,093 | $8,599 | 0.0% | 0% | -67.9% |
| 22 | BARCLAYS PLCNEW | 561 | $1,560 | 0.0% | 0% | new |
| 23 | MORGAN STANLEY | 510 | $1,418 | 0.0% | 0% | 0.0% |
| 24 | TD Waterhouse Canada Inc. | 63 | $178 | 0.0% | 0% | 0.0% |
| 25 | SBI Securities Co., Ltd. | 11 | $31 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.